Prognostic value of tumor-infiltrating immune cells and immune checkpoints in elderly head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiotherapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic value of tumor-infiltrating immune cells and immune checkpoints in elderly head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiotherapy
Authors
Keywords
-
Journal
Radiation Oncology
Volume 17, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-11-14
DOI
10.1186/s13014-022-02153-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma
- (2022) Hussein A. Tawbi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age-specific oncogenic pathways in head and neck squamous cell carcinoma - are elderly a different subcategory?
- (2022) Martine Froukje van der Kamp et al. CELLULAR ONCOLOGY
- Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer
- (2022) An-Ping Shi et al. Frontiers in Immunology
- Head and Neck Squamous Cell Carcinoma in Elderly Patients: Role of Radiotherapy and Chemotherapy
- (2022) Morena Fasano et al. Cancers
- Patterns-of-Care Analysis for Radiotherapy of Elderly Head-and-Neck Cancer Patients: A Trinational Survey in Germany, Austria and Switzerland
- (2022) Erik Haehl et al. Frontiers in Oncology
- Relationship Between Programmed Death Ligand 1 Expression and Other Clinicopathological Features in a Large Cohort of Gastric Cancer Patients
- (2022) Xinhua Chen et al. Frontiers in Immunology
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Increasing Mean Age of Head and Neck Cancer Patients at a German Tertiary Referral Center
- (2021) Julius M. Vahl et al. Cancers
- Prognostic Significance of CD4+ and CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
- (2021) Daniele Borsetto et al. Cancers
- Phase I/Ib clinical trial of Sabatolimab, an Anti-TIM-3 Antibody, Alone and in Combination With Spartalizumab, an Anti-PD-1 Antibody, in Advanced Solid Tumors
- (2021) Giuseppe Curigliano et al. CLINICAL CANCER RESEARCH
- Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
- (2021) Nancy Y Lee et al. LANCET ONCOLOGY
- Spatial Intratumoral Heterogeneity Expression of PD-L1 Antigen in Head and Neck Squamous Cell Carcinoma
- (2021) Nir Hirshoren et al. ONCOLOGY
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group
- (2021) Benjamin Lacas et al. RADIOTHERAPY AND ONCOLOGY
- Tumor-Infiltrating Lymphocytes in the Tumor Microenvironment of Laryngeal Squamous Cell Carcinoma: Systematic Review and Meta-Analysis
- (2021) Juan P. Rodrigo et al. Biomedicines
- Immune Aging and Immunotherapy in Cancer
- (2021) Melanie Kaiser et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immunohistochemistry-based hypoxia-immune prognostic classifier for head-and-neck cancer patients undergoing chemoradiation – Post-hoc analysis from a prospective imaging trial
- (2021) Alexander Rühle et al. RADIOTHERAPY AND ONCOLOGY
- The Role of Soluble LAG3 and Soluble Immune Checkpoints Profile in Advanced Head and Neck Cancer: A Pilot Study
- (2021) Andrea Botticelli et al. Journal of Personalized Medicine
- Prognostic Significance of PD-L1 Expression In Patients With Primary Oropharyngeal Squamous Cell Carcinoma: A Meta-Analysis
- (2021) Jerry Polesel et al. Frontiers in Oncology
- The Prognostic Implications of Tumor Infiltrating Lymphocytes in Colorectal Cancer: A Systematic Review and Meta-Analysis
- (2020) Gregory E. Idos et al. Scientific Reports
- Age-related changes in T lymphocytes of patients with head and neck squamous cell carcinoma
- (2020) S. S. Jeske et al. Immunity & Ageing
- Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma
- (2020) Zi Mei et al. International Journal of Oral Science
- Comparison of three PD-L1 immunohistochemical assays in head and neck squamous cell carcinoma (HNSCC)
- (2020) Emma J. de Ruiter et al. MODERN PATHOLOGY
- The Value of Laboratory Parameters for Anemia, Renal Function, Systemic Inflammation and Nutritional Status as Predictors for Outcome in Elderly Patients with Head-and-Neck Cancers
- (2020) Alexander Rühle et al. Cancers
- Lymphocyte Infiltration Determines the Hypoxia-Dependent Response to Definitive Chemoradiation in Head-and-Neck Cancer – Results from a Prospective Imaging Trial
- (2020) Nils H Nicolay et al. JOURNAL OF NUCLEAR MEDICINE
- Development and validation of a novel prognostic score for elderly head-and-neck cancer patients undergoing radiotherapy or chemoradiation
- (2020) Alexander Rühle et al. RADIOTHERAPY AND ONCOLOGY
- CD96 Is an Immune Checkpoint That Regulates CD8+ T-cell Antitumor Function
- (2019) Deepak Mittal et al. Cancer Immunology Research
- Expression analysis and significance of PD-1, LAG-3 and TIM-3 in human non-small cell lung cancer using spatially-resolved and multiparametric single-cell analysis.
- (2019) Ila J Datar et al. CLINICAL CANCER RESEARCH
- KEYNOTE-689: Phase 3 study of adjuvant and neoadjuvant pembrolizumab combined with standard of care (SOC) in patients with resectable, locally advanced head and neck squamous cell carcinoma.
- (2019) Ravindra Uppaluri et al. JOURNAL OF CLINICAL ONCOLOGY
- Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update
- (2019) Julian Biau et al. RADIOTHERAPY AND ONCOLOGY
- Prognostic impacts of the combined positive score and the tumor proportion score for programmed death ligand-1 expression by double immunohistochemical staining in patients with advanced gastric cancer
- (2019) Kohei Yamashita et al. Gastric Cancer
- Young and elderly oral squamous cell carcinoma patients present similar angiogenic profile and predominance of M2 macrophages: Comparative immunohistochemical study
- (2019) Lucas R. Teixeira et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Prognostic Value of Tumor-Infiltrating Lymphocytes in Head and Neck Squamous Cell Carcinoma
- (2019) Matthew E. Spector et al. JAMA Otolaryngology-Head & Neck Surgery
- Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
- (2019) Barbara Burtness et al. LANCET
- Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial
- (2019) Anthony C Nichols et al. LANCET ONCOLOGY
- Prognostic Role of Tumor-Infiltrating Lymphocytes in Esophagus Cancer: a Meta-Analysis
- (2018) Xiao Zheng et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapy
- (2018) Stefan Schmidt et al. CLINICAL CANCER RESEARCH
- Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
- (2018) Robert L. Ferris et al. ORAL ONCOLOGY
- The role of osteopontin in the progression of solid organ tumour
- (2018) Hailin Zhao et al. Cell Death & Disease
- The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis
- (2018) Wei-fa Yang et al. ORAL ONCOLOGY
- TIM-3 expression in breast cancer
- (2018) Samantha Burugu et al. OncoImmunology
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)
- (2017) Panagiotis Balermpas et al. INTERNATIONAL JOURNAL OF CANCER
- T-cell immunoglobulin mucin 3 blockade drives an antitumor immune response in head and neck cancer
- (2017) Jian-Feng Liu et al. Molecular Oncology
- PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma
- (2017) Tim Müller et al. Oncotarget
- The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis
- (2017) Emma J. de Ruiter et al. OncoImmunology
- Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG
- (2016) A. Linge et al. CLINICAL CANCER RESEARCH
- Obesity accelerates T cell senescence in murine visceral adipose tissue
- (2016) Kohsuke Shirakawa et al. JOURNAL OF CLINICAL INVESTIGATION
- CD274/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity
- (2016) Melanie Straub et al. Oncotarget
- LAG-3 confers poor prognosis and its blockade reshapes antitumor response in head and neck squamous cell carcinoma
- (2016) Wei-Wei Deng et al. OncoImmunology
- PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients
- (2016) Hye Ryun Kim et al. Scientific Reports
- Prognostic Role of Tumor-Infiltrating Lymphocytes in Lung Cancer: a Meta-Analysis
- (2015) Yiting Geng et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Systemic Immune Activity Predicts Overall Survival in Treatment-Nai ve Patients with Metastatic Pancreatic Cancer
- (2015) M. R. Farren et al. CLINICAL CANCER RESEARCH
- CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG)
- (2015) Panagiotis Balermpas et al. INTERNATIONAL JOURNAL OF CANCER
- High PD-L1 Expression Correlates with Metastasis and Poor Prognosis in Oral Squamous Cell Carcinoma
- (2015) Yueh-Min Lin et al. PLoS One
- Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer
- (2013) P Balermpas et al. BRITISH JOURNAL OF CANCER
- Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines
- (2013) Vincent Grégoire et al. RADIOTHERAPY AND ONCOLOGY
- CD8-alpha T-cell infiltration in human papillomavirus-related oropharyngeal carcinoma correlates with improved patient prognosis
- (2012) Alain C. Jung et al. INTERNATIONAL JOURNAL OF CANCER
- CD44: A Cancer Stem Cell-Related Biomarker with Predictive Potential for Radiotherapy
- (2010) M. Baumann et al. CLINICAL CANCER RESEARCH
- Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
- (2010) K. Kian Ang et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1+ memory phenotype CD4+ T cells expressing C/EBP underlie T cell immunodepression in senescence and leukemia
- (2009) K. Shimatani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now